Physician profile
Johnson Yates Congleton
NPI 1548897622
$1,323.18
in general payments reported to CMS, 2019-2025
17 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $290.18 | 2025 | Barrigel |
| Photocure INC | $237.86 | 2025 | Cysview |
| Boston Scientific Corporation | $223.03 | 2025 | General - Female Sui, Axonics, General - Kidney Stone Disease |
| Urogen Pharma, INC. | $117.68 | 2025 | |
| Abbvie INC. | $84.17 | 2025 | |
| Sumitomo Pharma America, INC. | $65.67 | 2025 | Gemtesa |
| Procept Biorobotics Corporation | $45.51 | 2025 | |
| Progenics Pharmaceuticals, INC. | $41.26 | 2025 | |
| Endo USA, INC. | $38.21 | 2025 | Xiaflex, Aveed |
| Valencia Technologies Corporation | $30.84 | 2025 | Ecoin Device Kit |
| Antares Pharma, INC. | $28.08 | 2025 | Xyosted |
| Millicent US INC | $23.67 | 2025 | Intrarosa |
| Janssen Biotech, INC. | $22.44 | 2025 | Erleada |
| Immunitybio, INC. | $22.00 | 2025 | |
| Pfizer INC. | $19.20 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $18.03 | 2025 | Illuccix |
| Abc Home Medical Supply, INC. | $15.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnson Congleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.